Champions Oncology (CSBR) Operating Income (2010 - 2026)

Champions Oncology has reported Operating Income for 17 years, with the latest figure at -$522000.0 in Q2 2026.

• On a quarterly basis, Operating Income rose 73.99% year-over-year to -$522000.0 in Q2 2026; TTM through Apr 2026 was -$1.1 million, a 125.04% decrease from a year earlier, with the FY2026 full-year figure at -$1.1 million, down 125.04% from the prior year.
• Operating Income was -$522000.0 for Q2 2026 at Champions Oncology, down from -$276000.0 in the prior quarter.
• The five-year high for Operating Income was $4.5 million in Q1 2025, with the low at -$2.6 million in Q1 2024.
• Average Operating Income over 5 years is -$482166.7, with a median of -$297500.0 recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Operating Income slumped 28028.57% in 2023, then jumped 274.58% in 2025.
• Over 5 years, Operating Income stood at $7000.0 in 2022, then plunged by 28028.57% to -$2.0 million in 2023, then surged by 137.44% to $732000.0 in 2024, then slumped by 74.73% to $185000.0 in 2025, then tumbled by 382.16% to -$522000.0 in 2026.
• The last three Operating Income figures came in at -$522000.0 (Q2 2026), -$276000.0 (Q1 2026), and $185000.0 (Q4 2025), per Business Quant data.